| Literature DB >> 32494044 |
Cecilia S Lee1, Michael L Lee2, Ryan T Yanagihara3, Aaron Y Lee3.
Abstract
BACKGROUND/Entities:
Mesh:
Year: 2020 PMID: 32494044 PMCID: PMC8027027 DOI: 10.1038/s41433-020-1003-0
Source DB: PubMed Journal: Eye (Lond) ISSN: 0950-222X Impact factor: 4.456
Baseline demographic factors of study population.
| Initially seen by optometrist | Initially seen by ophthalmologist | Total | |
|---|---|---|---|
| 706,581 | 375,563 | 1,082,144 | |
| Age decade ( | |||
| <10 | 29,062 (4.1) | 28,744 (7.7) | 57,806 (5.3) |
| 10–19 | 79,964 (11.3) | 25,293 (6.7) | 105,257 (9.7) |
| 20–29 | 88,591 (12.5) | 20,224 (5.4) | 108,815 (10.1) |
| 30–39 | 86,626 (12.3) | 24,126 (6.4) | 110,752 (10.2) |
| 40–49 | 128,102 (18.1) | 47,038 (12.5) | 175,140 (16.2) |
| 50–59 | 141,941 (20.1) | 72,090 (19.2) | 214,031 (19.8) |
| 60–69 | 117,669 (16.7) | 106,585 (28.4) | 224,254 (20.7) |
| 70+ | 34,540 (4.9) | 51,420 (13.7) | 85,960 (7.9) |
| Sex ( | |||
| Male | 294,674 (41.7) | 162,286 (43.2) | 456,960 (42.2) |
| Female | 409,133 (57.9) | 212,866 (56.7) | 621,999 (57.5) |
| Other/unknown | 2774 (0.4) | 411 (0.1) | 3185 (0.3) |
aSome cases (<0.1%) were missing age.
Fig. 1Kaplan–Meier curves on narrow angle detection in patients grouped by type of provider (a) and sex (b). X-axis: years since the first eye evaluation.
Y-axis: percent of study population who has not received laser peripheral iridotomy (LPI). a Purple: patients seen by optometrists; Orange: patients seen by ophthalmologists; b Yellow: male; Green: female.
Fig. 2Kaplan-Meier curves on narrow angle detection in patients seen by either optometrists (purple) or ophthalmologists (orange), stratified by decades of life.
X-axis: years since the first eye evaluation. Y-axis: percent of study population who has not received laser peripheral iridotomy (LPI). a age group 20–29; b 30–39; c 40–49; d 50-59; e 60–69; f 70+.
Cox regression model for laser peripheral iridotomy as the outcome controlling for time × provider interaction effect.
| Provider or age category | Hazard ratio | 95% CI | |
| Ophthalmology | Reference group | ||
| Optometry | 0.54 | 0.50–0.59 | <2e–16*** |
| 0–10 | Reference group | ||
| 11–20 | 1.73 | 0.74–4.10 | 0.205 |
| 21–30 | 4.50 | 2.04–9.91 | 0.00019*** |
| 31–40 | 10.47 | 4.89–22.43 | 1.49e–09*** |
| 41–50 | 27.90 | 13.22–58.74 | <2e–16*** |
| 51–60 | 46.12 | 21.94–96.96 | <2e–16*** |
| 61–70 | 68.37 | 32.55–143.61 | <2e–16*** |
| 70–80 | 56.75 | 26.94–119.56 | <2e–16*** |
| Female | Reference group | ||
| Male | 0.68 | 0.64–0.73 | <2e–16*** |
| Provider × time interaction | 1.19 | 1.05–1.34 | 0.0047** |
**p < 0.01; ***p < 0.001.